| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/30/2003 | WO2001066804A3 Methods for optimizing hybridization performance of polynucleotide probes and localizing and detecting sequence variations |
| 05/30/2003 | CA2644157A1 Electrodes, methods, apparatuses comprising micro-electrode arrays |
| 05/30/2003 | CA2584931A1 Increasing the concentration of a nucleic acid |
| 05/30/2003 | CA2480566A1 Materials and methods for releasing genetic material |
| 05/30/2003 | CA2468170A1 Method for identification of tumor targeting enzymes |
| 05/30/2003 | CA2468107A1 Methods for identifying and validating potential drug targets |
| 05/30/2003 | CA2468096A1 Method for production of asymmetric carotenoids |
| 05/30/2003 | CA2468041A1 Optical bio-discs and microfluidic devices for analysis of cells |
| 05/30/2003 | CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 05/30/2003 | CA2467740A1 Methods and apparatus for blood typing with optical bio-discs |
| 05/30/2003 | CA2467717A1 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| 05/30/2003 | CA2467629A1 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 05/30/2003 | CA2467577A1 Multiplex pcr |
| 05/30/2003 | CA2467563A1 Cell and tissue arrays and microarrays and methods of use |
| 05/30/2003 | CA2467460A1 Multiplex oligonucleotide addition and target amplification |
| 05/30/2003 | CA2467456A1 Method of using a non-antibody protein to detect and measure an analyte |
| 05/30/2003 | CA2467455A1 Method of detection of prostate cancer |
| 05/30/2003 | CA2467248A1 Automated sample preparation methods and devices |
| 05/30/2003 | CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/30/2003 | CA2467050A1 Method for detecting analyte(s) using magnetic colloidal particles |
| 05/30/2003 | CA2467020A1 Tumor specific monoclonal antibodies |
| 05/30/2003 | CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 05/30/2003 | CA2463862A1 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking |
| 05/30/2003 | CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 05/30/2003 | CA2462819A1 Method and kit for proximity probing with multivalent proximity probes |
| 05/30/2003 | CA2458615A1 Flow-controlled magnetic particle manipulation |
| 05/30/2003 | CA2445941A1 Visually determinable atp measuring method and reagent therefor |
| 05/30/2003 | CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
| 05/30/2003 | CA2413177A1 Methods for detecting cells with numerical chromosomal abnormalities |
| 05/29/2003 | US20030101002 Methods for analyzing gene expression patterns |
| 05/29/2003 | US20030100842 Method and kit for indicating the level of bad breath |
| 05/29/2003 | US20030100747 Polymorphisms in the region of the human hemochromatosis gene |
| 05/29/2003 | US20030100746 Methods and materials relating to fibulin-like polypeptides and polynucleotides |
| 05/29/2003 | US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders |
| 05/29/2003 | US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 05/29/2003 | US20030100541 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/29/2003 | US20030100540 Identification of NSAID-regulated genes |
| 05/29/2003 | US20030100529 Detecting a signal resulting from specifically hybridizing a tissue with a nucleic acid probe that contains a (anti)sense portion of kalinin/laminin 5 gamma-2 chain nucleic acid sequence |
| 05/29/2003 | US20030100528 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 05/29/2003 | US20030100527 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 05/29/2003 | US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 05/29/2003 | US20030100504 Treatment and diagnosis of insulin-resistant states |
| 05/29/2003 | US20030100489 For determining if a subject is at risk for a disorder characterized by unwanted cell proliferation |
| 05/29/2003 | US20030100485 Human neurotrimin homolog |
| 05/29/2003 | US20030100484 Cell in which a urotensin II receptor is formed is contacted with a chemical compound; activity or quantity of a gene, or its gene product, from the cell from is determined, comparing with gene product of control cell |
| 05/29/2003 | US20030100479 Gene polymorphisms and response to treatment |
| 05/29/2003 | US20030100476 Effect of COMT genotype on frontal lobe function |
| 05/29/2003 | US20030100130 Crystal compound for use as tool in medical and nonmedical fluorescence microscopy, histology, flow cytometry, in situ hybridization, immunoassays and nucleotide sequences separation and determination |
| 05/29/2003 | US20030100129 Multi-partite ligands and methods of identifying and using same |
| 05/29/2003 | US20030100125 Filtering particles from liquid sample; obtain fluid sample, deposit on filter, determine time it took for fluid to pass through filter, compare to control |
| 05/29/2003 | US20030100122 Detection of bacterial infection in mammals; obtain body fluid or tissue, determine concentration of 3-chlorotyrosine or 3-bromotyrosine in tissue, compare to control, amplified concentrations indicate infections |
| 05/29/2003 | US20030100104 Apparatus for use in the detection of a microorganism in sample |
| 05/29/2003 | US20030100102 Apparatus and method for sequencing a nucleic acid |
| 05/29/2003 | US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 05/29/2003 | US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders |
| 05/29/2003 | US20030100077 In vitro method to create circular molecules for use in transformation |
| 05/29/2003 | US20030100068 RANKL mimics and uses thereof |
| 05/29/2003 | US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2003 | US20030100059 Novel cell-based assays for G-protein-coupled receptor-mediated activities |
| 05/29/2003 | US20030100039 Novel human phospholipase c delta 5 |
| 05/29/2003 | US20030100037 Detection of modulators of preferential enzymatic activity; obtain enzymatic polypeptide, incubate with test modulator, monitor association or dissociation of polypeptides, dissociation indicates presence of modulator |
| 05/29/2003 | US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer |
| 05/29/2003 | US20030100033 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals |
| 05/29/2003 | US20030100027 Methods and compositions using coiled binding partners |
| 05/29/2003 | US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor |
| 05/29/2003 | US20030100025 Detection of inhibitors of ecdysteroid biosynthesis; obtain ecdysteroid biosynthetic enzyme, incubate with modulator, monitor adjustment in enzyme activity, reduction in enzyme activity indicates inhibitor of ecdysteriod biosynthesis |
| 05/29/2003 | US20030100024 Detection of morphological adjustments in cell; obtain cells, deposit on solid support, label cell structures, scan cells, detect signal, evaluate cells for morphological adjustments |
| 05/29/2003 | US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity |
| 05/29/2003 | US20030100020 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/29/2003 | US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes |
| 05/29/2003 | US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease |
| 05/29/2003 | US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent |
| 05/29/2003 | US20030100006 Shot-gun sequencing and amplification without cloning |
| 05/29/2003 | US20030100005 CRBs as modifiers of branching morphogenesis and methods of use |
| 05/29/2003 | US20030100002 Methods for preventing or reducing multiple antibiotic resistance in bacteria |
| 05/29/2003 | US20030099999 Assay procedure using fluorogenic tracers |
| 05/29/2003 | US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/29/2003 | US20030099997 Method for gene identification based on differential DNA methylation |
| 05/29/2003 | US20030099993 Detection of DNA hybridization on surfaces |
| 05/29/2003 | US20030099992 Genes associated with mast cell activation |
| 05/29/2003 | US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder |
| 05/29/2003 | US20030099989 Fluorescent probes for chromosome painting |
| 05/29/2003 | US20030099987 Methods and compositions for the detection of chromosomal aberrations |
| 05/29/2003 | US20030099986 Solid support for use in the detect of preferential nucleotide sequences in sample |
| 05/29/2003 | US20030099985 Amplified gene involved in cancer |
| 05/29/2003 | US20030099979 Diagnosing asthmatic response; obtain tissue sample, extract nnucleotide sequences, incubate with probe for marker gene, measure gene expression, evaluate for asthma response |
| 05/29/2003 | US20030099978 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) |
| 05/29/2003 | US20030099977 Genotyping human UDP-glucuronsyltransferase 2B15 (UGT2B15) genes |
| 05/29/2003 | US20030099976 Androgen receptor complex-associated protein |
| 05/29/2003 | US20030099975 Detection of fungal pathogens using the polymerase chain reaction |
| 05/29/2003 | US20030099972 Nucleotide sequences conjugate for use as diagnostic tool in genetic engineering |
| 05/29/2003 | US20030099971 Epidermal differentiation factor |
| 05/29/2003 | US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 05/29/2003 | US20030099968 Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| 05/29/2003 | US20030099964 Methods for genomic analysis |
| 05/29/2003 | US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 05/29/2003 | US20030099962 Generation of preferential vector; obtain single stranded nuclleotide sequences, incubate with primers, nucleotides and polymerase, generate nucleotide sequences, recover nucleotide sequences and regenerate vector |
| 05/29/2003 | US20030099961 Nucleotide sequences for use as amplification tools in genetic engineering |
| 05/29/2003 | US20030099960 Compositions and methods for optimizing UGT2B7 substrate dosings and for predicting UGT2B7 substrate toxicity |
| 05/29/2003 | US20030099958 Detection of vascular system disorders; obtain nucleotide sequence sample, sequence, detect polymorphisms, evaluate for vascular system disorders |